Ann: Appendix 4C - quarterly, page-4

I do like how they added this notation into the "Cash & Cash Equivalents" section (notation below) with the figure of $55,143,000 to let everyone know that they actually have $95,143,000 and basically outlining that net debt is zero once this is taken into account ! (Drawn down debt is $65m from two facilities with available limit of $115m)


_{*Additionally US$40.0 million in gross cash proceeds were received from Tasly Pharmaceutical Group on October 11, 2018 pursuant to a Development and Commercialization Agreement (US$20.0m) and an Investment Agreement (US$20.0m) signed on July 17, 2018.}